Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Cogent Biosciences Inc.

    World Rank (Jan-05-2024)
    12,548
    Market Cap (Jan-05-2024)
    0.504 Billion USD
    World Rank (Jul-30-2023)
    8,448
    Market Cap (Jul-30-2023)
    1.061 Billion USD
    World Rank (Dec-25-2022)
    9,806
    Market Cap (Dec-25-2022)
    0.768 Billion USD
    World Rank (Jan-07-2022)
    16,133
    Market Cap (Jan-07-2022)
    0.33 Billion USD
    Headquarters Country
    USA
    Company Profile

    Cogent Biosciences, Inc is a biotechnology company developing real solutions to treat genetically driven diseases. The headquarters is in USA.

    Facts About Company

    Cogent Biosciences, Inc Annual Net loss for year ending Dec-2022 was -140 million USD.

    Cogent Biosciences, Inc Annual Net loss for year ending Dec-2021 was -72 million USD.

    As on 2022, Cogent Biosciences, Inc has 138 employees.

    Company Website
    COGENT BIOSCIENCES, INC.

  2. Lyell Immunopharma

    World Rank (Jan-05-2024)
    12,587
    Market Cap (Jan-05-2024)
    0.501 Billion USD
    World Rank (Jul-30-2023)
    10,406
    Market Cap (Jul-30-2023)
    0.734 Billion USD
    World Rank (Dec-25-2022)
    9,885
    Market Cap (Dec-25-2022)
    0.760 Billion USD
    World Rank (Jan-07-2022)
    7,342
    Market Cap (Jan-07-2022)
    1.53 Billion USD
    Annual Revenue in USD
    11 Million USD
    Annual Operating Income in USD
    -214 Million USD
    Annual Net Income in USD
    -250 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Lyell Immunopharma is a Biotechnology company in the fields of oncology and adoptive cell therapy. The company is in cell and gene therapy companies including Atara, Juno Therapeutics and Sangamo; oncology therapeutic development companies including Amgen, AstraZeneca, Genentech, Incyte and Seagen and cancer diagnostic companies including Genomic Health, GRAIL and Illumina. The headquarters is in USA.
    Company Website
    LYELL IMMUNOPHARMA

  3. Organogenesis Holdings

    World Rank (Jan-05-2024)
    12,742
    Market Cap (Jan-05-2024)
    0.490 Billion USD
    World Rank (Jul-30-2023)
    12,042
    Market Cap (Jul-30-2023)
    0.560 Billion USD
    World Rank (Dec-25-2022)
    14,958
    Market Cap (Dec-25-2022)
    0.339 Billion USD
    World Rank (Jan-07-2022)
    9,086
    Market Cap (Jan-07-2022)
    1.06 Billion USD
    Annual Revenue in USD
    450 Million USD
    Annual Operating Income in USD
    22 Million USD
    Annual Net Income in USD
    16 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Organogenesis Holdings is a Regenerative Medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care and surgical and sports medicine markets. The headquarters is in USA.
    Facts About Company
    Organogenesis Holdings company annual revenue was 450 million USD and annual net income was 15 million USD as on Dec-2022.
    Company Website
    ORGANOGENESIS HOLDINGS

  4. Oric Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    12,752
    Market Cap (Jan-05-2024)
    0.489 Billion USD
    World Rank (Jul-30-2023)
    14,604
    Market Cap (Jul-30-2023)
    0.372 Billion USD
    World Rank (Dec-25-2022)
    17,297
    Market Cap (Dec-25-2022)
    0.229 Billion USD
    World Rank (Jan-07-2022)
    12,703
    Market Cap (Jan-07-2022)
    0.56 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    ORIC Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on discovering and developing innovative therapies that benefit patients with cancer. The company annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
    Company Website
    ORIC PHARMACEUTICALS, INC.

  5. Janux Therapeutics Inc.

    World Rank (Jan-05-2024)
    12,817
    Market Cap (Jan-05-2024)
    0.484 Billion USD
    World Rank (Jul-30-2023)
    11,423
    Market Cap (Jul-30-2023)
    0.617 Billion USD
    World Rank (Dec-25-2022)
    12,494
    Market Cap (Dec-25-2022)
    0.494 Billion USD
    World Rank (Jan-07-2022)
    10,875
    Market Cap (Jan-07-2022)
    0.77 Billion USD
    Annual Revenue in USD
    9 Million USD
    Annual Operating Income in USD
    -67 Million USD
    Annual Net Income in USD
    -63 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Website
    JANUX THERAPEUTICS, INC.

  6. Nurix Therapeutics Inc.

    World Rank (Jan-05-2024)
    12,883
    Market Cap (Jan-05-2024)
    0.478 Billion USD
    World Rank (Jul-30-2023)
    13,148
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    12,559
    Market Cap (Dec-25-2022)
    0.489 Billion USD
    World Rank (Jan-07-2022)
    8,355
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Annual Revenue in USD
    29 Million USD
    Annual Net Income in USD
    -117 Million USD
    Annual Results for Period Ending
    Nov-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nurix Therapeutics is a  Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
    Company Website
    NURIX THERAPEUTICS, INC.

  7. Procaps Group S.A.

    World Rank (Jan-05-2024)
    12,936
    Market Cap (Jan-05-2024)
    0.474 Billion USD
    World Rank (Jul-30-2023)
    13,598
    Market Cap (Jul-30-2023)
    0.437 Billion USD
    World Rank (Dec-25-2022)
    11,197
    Market Cap (Dec-25-2022)
    0.607 Billion USD
    Headquarters Country
    Luxembourg
    Company Website
    PROCAPS GROUP S.A.

  8. Phibro Animal Health Corporation

    World Rank (Jan-05-2024)
    12,974
    Market Cap (Jan-05-2024)
    0.471 Billion USD
    World Rank (Jul-30-2023)
    11,793
    Market Cap (Jul-30-2023)
    0.582 Billion USD
    World Rank (Dec-25-2022)
    11,658
    Market Cap (Dec-25-2022)
    0.563 Billion USD
    World Rank (Jan-07-2022)
    10,512
    Market Cap (Jan-07-2022)
    0.82 Billion USD
    Annual Revenue in USD
    942 Million USD
    Annual Net Income in USD
    49 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Phibro Animal Health is a contributing to a healthy and affordable food supply company by helping farmers responsibly care for their animals. The company products are Beef Cattle, Swine, Poultry, Dairy Cattle, Aqua, Mineral Nutrition, Ethanol and Performance Products. The company annual revenue is 799 million USD and 1,600 employees as on 2020. The headquarters is in USA.
    Company Website
    PHIBRO ANIMAL HEALTH CORPORATION

  9. Entrada Therapeutics Inc.

    World Rank (Jan-05-2024)
    13,007
    Market Cap (Jan-05-2024)
    0.469 Billion USD
    World Rank (Jul-30-2023)
    11,889
    Market Cap (Jul-30-2023)
    0.574 Billion USD
    World Rank (Dec-25-2022)
    12,819
    Market Cap (Dec-25-2022)
    0.470 Billion USD
    World Rank (Jan-07-2022)
    15,307
    Market Cap (Jan-07-2022)
    0.37 Billion USD
    Headquarters Country
    USA
    Company Website
    ENTRADA THERAPEUTICS, INC.

  10. Fulcrum Therapeutics

    World Rank (Jan-05-2024)
    13,136
    Market Cap (Jan-05-2024)
    0.458 Billion USD
    World Rank (Jul-30-2023)
    17,105
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,206
    Market Cap (Dec-25-2022)
    0.325 Billion USD
    World Rank (Jan-07-2022)
    12,092
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Annual Revenue in USD
    19 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Fulcrum Therapeutics is a Clinical Stage Biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need with an initial focus on rare diseases. The company annual revenue is 8.82 million USD and 432 employees as on 2020. The headquarters is in USA.
    Company Website
    FULCRUM THERAPEUTICS

Share